Proscia has released DermAI, a module on Proscia’s Concentriq Platform that leverages deep learning to pre-screen and classify skin biopsies. Proscia intends to submit DermAI to the FDA for review to use in clinical diagnosis.

To learn more, click here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!